News and Trends 8 Mar 2023 Affibody and Chiesi Group to develop treatments for respiratory diseases Affibody AB and Chiesi Farmaceutici S.p.A have announced a collaboration and licensing agreement to develop and commercialize innovative treatments for respiratory diseases using Affibody’s proprietary technology. Under the terms of… March 8, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Startup Scout 1 Feb 2019 This Biotech Links the Gut Microbiome to Diseases Using Norwegian Poo …diseases. Mission: To rapidly screen thousands of stool samples from a Norwegian population study and link the gut microbiome with disease. Client companies will then be able to pay Bio-Me… February 1, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 29 Mar 2019 This Biotech Repurposes Drugs to Fight Huntington’s Disease Barcelona-based SOM Biotech is developing treatments for incurable diseases such as Huntington’s disease with drugs that are already on the market for other diseases. Mission: To repurpose commercially available drugs… March 29, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 1 Nov 2022 Human Immunology Biosciences launches with $120M Human Immunology Biosciences (HI-Bio), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), announced its launch with $120 million in financing. HI-Bio was incubated by… November 1, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 3 Aug 2022 Chinese biotech Sironax closes $200M funding round …multiple programs with a focus on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways and neuroinflammation. Age-related degenerative diseases Sironax plans to use the proceeds to… August 3, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Sponsored by ACROBiosystems 3 Nov 2022 Impacting vaccine development: COVID-19 and its implications for the future of vaccines …limited and currently lacking cures. However, because of the rarity of such diseases, the market potential of orphan vaccines developed to tackle orphan diseases may not always offset development costs…. November 3, 2022 - 8 minutesmins - By Sudha Sundaram Share WhatsApp Twitter Linkedin Email
News and Trends 3 Aug 2022 Full label approval given by FDA for eye disease drug, CIMERLI …decades, the burden of diabetic-related eye diseases, like DME and DR, are also likely to rise. As the prevalence of serious retinal diseases increases, so do the costs of treating… August 3, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 29 Nov 2016 New British Partnership set to Cure Rare Diseases with Gene Therapy Oxford BioMedica and Orchard Therapeutics are partnering up to bring gene therapy to the market and treat rare diseases for which no cure is available yet. Oxford BioMedica develops lentiviral… November 29, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 27 Apr 2023 Patients with asthma and other inflammatory lung diseases can be treated ‘in a fundamentally new way’ …advanced glycation end products (RAGE) as a potential treatment for inflammatory pulmonary diseases, such as asthma. These data represent the first clinical demonstration of the potential utility of Arrowhead Pharmaceuticals’… April 27, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 Feb 2025 Eight respiratory disease companies advancing innovative therapies in 2025 …diseases – one for inflammatory pulmonary diseases and one for idiopathic pulmonary fibrosis. The inflammatory pulmonary disease candidate is called ARO-RAGE. It is an RNAi therapeutic targeting the receptor for… February 27, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2022 A biotech boom manifesting real results in rare pediatric diseases …under-researched areas like rare pediatric genetic diseases. Deeply personal The issue is deeply personal to me. More than 20 years ago, while my wife was pregnant with our third child,… November 14, 2022 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 15 Sep 2022 Tridek-One brings in €16M to develop auto-immune diseases candidates …will primarily be used to identify development candidates against auto-immune diseases, to conduct IND-enabling studies and to further build the organization. The company previously raised €3 million ($3 million) in… September 15, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email